Product Information
FELODIPINE ER 2.5 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.1269 per EA under NDC 13668013205. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Felodipine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668013205
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FELODIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA202170FDA Approved
11/28/2011
TE Code
AB
On Market Since
11/28/2011
Pharmacological Classes
Price Statistics
The NADAC for FELODIPINE ER 2.5 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 74.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1269 per EA |
|---|---|
| All-time high | $0.6343 (Mar 12, 2014) |
| All-time low | $0.1123 (Jun 17, 2026) |
| 52-week high | $0.1677 |
| 52-week low | $0.1123 |
| Median price | $0.1963 |
| Average price | $0.2646 |
| Largest weekly change | +67.4% (Nov 22, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Felodipine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dihydropyridine Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FELODIPINE ER 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELODIPINE ER 2.5 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $0.1269 per EA (NDC 13668013205), effective Sep 30, 2026.
How has the price of FELODIPINE ER 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELODIPINE ER 2.5 MG TABLET has declined 74.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FELODIPINE ER 2.5 MG TABLET?
Since Nov 28, 2013, the NADAC for FELODIPINE ER 2.5 MG TABLET has ranged from a low of $0.1123 (Jun 17, 2026) to a high of $0.6343 (Mar 12, 2014), with a median of $0.1963 per EA.
Are there cheaper alternatives to FELODIPINE ER 2.5 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELODIPINE ER 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FELODIPINE ER 2.5 MG TABLET?
FELODIPINE ER 2.5 MG TABLET (NDC 13668013205) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.